General Motors reported Q2 results on July 21, and the market's reaction has been swift and unusually one-directional: analysts are raising targets en masse, the stock is up nearly 5% on the day, and options positioning has lurched toward its most call-heavy extreme in weeks.
The analyst response is the clearest signal of the day. Seven firms raised price targets on July 22 alone — and the direction is unambiguous. Goldman Sachs lifted its Buy-rated target from $91 to $103. JP Morgan pushed its Overweight target from $110 to $120. Barclays raised to $110 and TD Cowen moved to $132, the most aggressive on the Street. RBC and Morgan Stanley both nudged higher. The one outlier is Wells Fargo, which raised its Underweight target only marginally to $61 — a target that sits roughly 23% below the current $79.52 close and represents the lone dissenting voice in an otherwise constructive post-print reaction. The consensus mean price target now sits at $97.81, implying about 23% upside from current levels. The gap between the Wells Fargo bear case and the Goldman/JP Morgan bull cluster tells the whole story: this is a stock where the debate about EV transition costs and macro risk hasn't been resolved, just temporarily overwhelmed by a print that clearly exceeded lowered expectations.
Options positioning moved sharply with the stock. The put/call ratio jumped to 0.72 on July 21, running 2.5 standard deviations above its 20-day average of 0.65 — the highest relative reading in recent memory. At first glance that looks defensive, but reading it in context matters. Going into earnings the PCR had been sitting comfortably below 0.65, call-dominated, as the July 18 preview noted. The post-earnings spike to 0.72 likely reflects a mix of residual hedges being rolled and fresh call-buying activity that lifts gross volume on both sides — in a rising-tape session following a beat, elevated PCR can reflect dealers absorbing more two-way flow rather than a net defensive shift. Cost to borrow has also moved: it doubled week-over-week to 0.35%, a notable reversal from the 0.15% low touched earlier this week. That said, absolute levels remain low. Availability is effectively unconstrained — the lending pool dwarfs the short position at current levels — so the CTB move is a demand signal, not a supply squeeze.
Short interest is building again after the post-earnings print, though the level remains modest. Bears added roughly 1 million shares in the two sessions since July 21, pushing SI back to 2.95% of free float — up 2.5% on the week and 26% over the past month. The 30-day build is the same story documented in earlier notes: bears accumulated aggressively into earnings and haven't been flushed out by the stock's move. At $79.52, the stock is trading roughly 7% below where insiders were selling in late May and June, when CEO Mary Barra sold more than $22 million of stock across several transactions at prices around $85. That cluster of CEO sales — all executed in a tight band near $85 — now sits as a potential ceiling that bears will watch closely.
The factor picture is more supportive than it was a month ago. Forward EPS momentum ranks in the 90th percentile on a 12-month basis — the strongest single factor score in the dataset. Days-to-cover ranks in the 82nd percentile, reflecting the modest short position relative to average daily volume. Valuation is undemanding: P/E near 5.8x and EV/EBITDA around 6.9x, both of which have compressed slightly over the past 30 days as earnings estimates have held while the stock softened into the print. Price-to-book is fractionally below 1x — a level that historically attracts value-oriented institutional buyers. BlackRock and State Street were both adding modestly as of their last reported dates. The next earnings event is flagged for October 20, giving the post-Q2 narrative roughly three months to play out.
The watch list from here is tight: whether the $85 insider-sale level acts as near-term resistance, whether the fresh short build that survived the earnings beat accelerates or fades as the week closes, and whether Wells Fargo's lone Underweight finds any company as other firms reassess their post-print positioning.
See the live data behind this article on ORTEX.
Open GM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
